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GENOMICS AND PROTEOMICS
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Biology is in the midst of a revolution. Recent advances have occurred in virtually all areas
of the biological sciences. Two completely new fields of research, genomics and proteomics,
have the potential to radically advance our understanding of life and transform medicine.
Perspectives on these important fields of research are featured in this issue of The Yale
Journal of Biology and Medicine.
The effort to decode the sequence of the human genome has spawned a plethora of initia-
tives in gene discovery and high throughput analysis of gene and protein function. Indeed,
there has been a paradigm shift in biological research from the analysis of individual genes
and proteins to the global analysis of thousands of genes, proteins, and metabolites simul-
taneously. This advance has permitted entire pathways and systems to be studied in a single
research initiative and allowed more rapid, resource-effective, and fruitful investigations into
human health and disease.As an example, the cost of mapping a genetic disease has been
reduced more than 10-fold, thus resulting in a greater number of disease loci to be mapped.
Driving the shift to system-wide biological investigations have been amazing advances in
technologies. The development of DNAand protein microarrays allowed the analysis of the
expression of thousands of genes and the activities of thousands of proteins in a single ex-
periment. Recently, the advent of new DNAsequencing technologies resulted in the first re-
ports of complete DNAsequences of individuals as well as a variety of other advances. The
first of these new technologies, 454 SequencingTM, was launched commercially in 2006 and
led to myriad discoveries, including one of the first complete human genome sequences; the
sequencing of Neanderthal DNA; the sequencing of a major human pathogen, Acinetobacter
baumanni; the discovery of the large magnitude of structural variation in the human genome;
the attribution of bee colony collapse disorder to a new virus; and discovery of pathogens
that cause human disease. An effort is under way to sequence the genomes of 1,000 indi-
viduals from diverse parts of the world, and many companies are rushing to develop tech-
nologies striving to bring the cost of sequencing a human genome to $1,000.
As impressive as the advances in genomics have been, equally impressive are the ad-
vances in proteomics, the study of all proteins. We now can analyze thousands of proteins
at once using protein microarrays, and we can profile thousands of proteins using new tech-
niques in mass spectrometry. These latter technologies are expected to be particularly valu-
able in analyzing biological samples and in the discovery of biomarkers that might be useful
in the early detection of such illnesses as cancer, diabetes, and autoimmune diseases.
Nearly all of the latest technologies for genomics and proteomics are available at the Keck
Center or the Yale Center for Genomics and Proteomics.
The new DNA sequencing and proteomics technologies are expected to usher in an era of
personal genomics. In many cases, it should be possible to help pinpoint genetic propensi-
ties for particular diseases, the nature of the genetic defect once a disease is detected, and
predict the likelihood of response to particular therapies. Likewise, proteomics tools are ex-
pected to have applications for personalized medicine. Current gene- and protein-basedtests utilize a limited number of markers; in the future, they will likely use hundreds, if not
thousands, of markers.
In the articles herein, the reader will find descriptions of the new genomics and proteomics
technologies and interviews with their inventors and other leaders in the field. These de-
scriptions of how genomics and proteomics have helped us understand human health and
disease and their future potential will give the reader key insights into the revolution ongoing
in biology.
144 Snyder: Introduction